Immix Biopharma Inc. (IMMX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Immix Biopharma Inc.

    NASDAQ: IMMX · Real-Time Price · USD
    2.17
    0.02 (0.93%)
    At close: Sep 08, 2025, 3:59 PM
    2.15
    -0.88%
    After-hours: Sep 08, 2025, 04:29 PM EDT

    Immix Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a -89.52M n/a
    Cost of Revenue
    		 115.39K 5.47K 2.13K 2.47K
    Gross Profit
    		 -115.39K -5.47K -89.52M -2.47K
    Operating Income
    		 -22.67M -16.14M -8.22M -1.35M
    Interest Income
    		 1.02M 572.01K n/a 179.85
    Pretax Income
    		 -21.66M -15.57M -8.22M -24.38M
    Net Income
    		 -21.61M -15.43M -8.23M -24.38M
    Selling & General & Admin
    		 11.38M 7.41M 4.02M 1.23M
    Research & Development
    		 11.29M 8.74M 4.2M 126.53K
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 22.67M 16.14M 8.22M 1.35M
    Interest Expense
    		 n/a n/a 497.00 179.85K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 22.67M 16.14M 8.22M 1.35M
    Income Tax Expense
    		 41.04K 26.41K 10.27K 6.01K
    Shares Outstanding (Basic)
    		 28.29M 17.34M 13.23M 13.23M
    Shares Outstanding (Diluted)
    		 28.29M 17.34M 13.23M 13.23M
    EPS (Basic)
    		 -0.76 -0.89 -0.62 -1.84
    EPS (Diluted)
    		 -0.76 -0.89 -0.62 -1.84
    EBITDA
    		 -21.54M -16.14M -8.22M -1.35M
    EBIT
    		 -21.66M -16.14M -8.22M -1.35M
    Depreciation & Amortization
    		 115.39K 5.47K 2.13K 2.47K

    Add to Watchlist